NEW YORK (Reuters Health) – Compared to white light cystoscopy, hexaminolevulinate fluorescence cystoscopic detection of papillary, nonmuscle invasive bladder cancer appears superior, researchers report in a May 12th…
NEW YORK (Reuters Health) – Neoadjuvant treatment with erlotinib (Tarceva), an epidermal growth factor receptor (EGFR) inhibitor, can help downstage bladder cancer to organ-confined disease, thereby increasing the…